TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

書誌詳細
第一著者:	Afroza, Halima
その他の著者:	Talukder, Mesbah
フォーマット:	学位論文
言語:	English
出版事項:	Brac University 2024
主題:	Psoriasis Alopecia TNF-α inhibitor FAERS ROR Disproportionality analysis
オンライン･アクセス:	http://hdl.handle.net/10361/22075

類似資料

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
著者:: Islam, Nahidul
出版事項: (2023)

Isolation and identification of α-amylase producing soil microorganisms and partial characterization of α-Amylase enzyme
著者:: Tamanna, Shams Tahsin
出版事項: (2020)

Safety and efficacy of dutasteride for male Androgenetic Alopecia
著者:: Islam, S.M. Zahidul
出版事項: (2024)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
著者:: Khandker, Tahia Anjum
出版事項: (2024)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
著者:: Akter, Anika
出版事項: (2022)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
著者:: Meem, Manila
出版事項: (2023)

Inhibition of Fibroblast Activation Protein alpha (FAP-α) in Colorectal Cancer
著者:: Tabassum, Azwada
出版事項: (2021)

Identification of FAP inhibitors using in silico simulation study
著者:: Deeba, Maliha Tasnim
出版事項: (2018)

Biologics and Biosimilars as Treatment Options for Psoriasis
著者:: Moya, Amena Khatun
出版事項: (2023)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
著者:: Onanna, Kazi
出版事項: (2024)

Efficacy and safety of monotherapy and combination therapy of oral minoxidil for androgenetic alopecia: a structured review
著者:: Jahan, Safrin
出版事項: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
著者:: Islam, Saidul
出版事項: (2022)

Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
著者:: Bishakha, Adwiza Chakraborty
出版事項: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
著者:: Bakar, Osama Bin Abu
出版事項: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Flora, Sanzida Alam
出版事項: (2024)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
著者:: Karim, Azrin
出版事項: (2024)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
著者:: Oshin, Sadia Afrin
出版事項: (2021)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
著者:: Haque, Mushfiqul
出版事項: (2019)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
著者:: Mahin, Md. Tamjidur Rahman
出版事項: (2024)

Female Alopecia
著者:: TrÃ¼eb
出版事項: (2013)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
著者:: Khan, Muidul Hasan
出版事項: (2024)

Induced pluripotent stem cells: a novel tool for modelling and treating Parkinson’s disease
著者:: Tanin, Nahid Sultana
出版事項: (2022)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
著者:: Sorno, Rubina Haque
出版事項: (2024)

Detection of skin diseases using deep learning
著者:: Shodoy, Masuk Ur Rahman
出版事項: (2024)

Pharmacoepidemiology and Pharmacovigilance

Synthesis and sar o acne medication
著者:: Naureen, Tasnia
出版事項: (2024)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
著者:: Fred, Namanda Rogers
出版事項: (2021)

Importance of biologically active agents over other therapies in Rheumatoid Arthritis- a review
著者:: Mehreen, Elnaj
出版事項: (2021)

HPLC method development for the analysis of linagliptin
著者:: Mimiya, Ruhani Amrin
出版事項: (2020)

RIPK pathway, as a potential target, for cancer treatment - a review
著者:: Jahan, Nusrat
出版事項: (2024)

Importance of biologics in rheumatoid arthritis management
著者:: Riyadh, S. M.
出版事項: (2022)

Pharmacovigilance in the European Union
著者:: Kaeding
出版事項: (2017)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
著者:: Ratu, Tabassum
出版事項: (2024)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
著者:: Nour, Sabrina
出版事項: (2019)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
著者:: Ishrat, Nowshin
出版事項: (2024)

Immunotherapy in the Management of Lung Cancer
著者:: Tasnim, Humayra
出版事項: (2022)

Recent advances in Cancer treatment targeting autophagy and future aspects
著者:: Emon, Kamrul Hasan
出版事項: (2022)

Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
著者:: Rahman, Towsifur
出版事項: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
著者:: Mirza, Maisa Tasnim
出版事項: (2023)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
著者:: Rahman, Ahadina
出版事項: (2018)